MedTrace Logo

Rate of Tranexamic Acid Administration on Blood Pressure (RateTXA) Study.

NCT06356948 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2024-04-10

No results posted yet for this study

Summary

Tranexamic acid is a well-established treatment for post-partum hemorrhage. This study aims to examine the effect of tranexamic acid administration rates on blood pressure changes over 1 minute compared to 10 minutes in healthy pregnant patients scheduled for cesarean delivery.

Conditions

  • Healthy Participants

Interventions

DRUG

Tranexamic Acid (TXA)

Study drug administration

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Anton Chau, MD MMSc · Department of Anesthesia BC Women's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-30
Primary Completion
2027-07-30
Completion
2027-12-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06356948 on ClinicalTrials.gov